From: Summary of 615 patients of chronic myeloid leukemia in Shanghai from 2001 to 2006
HU | IFN(+Ara-C) | Imatinib | HSCT | |
---|---|---|---|---|
n = 70(%) | n = 184(%) | n = 154(%) | n = 21(%) | |
CHR n(%) | 44(62.9) | 139(75.5) | 142(92.2) | 17(81.0) |
MCyR n(%) | 0 | 37(20.1) | 116(75.3) | 15(71.4) |
CCyR n(%) | 0 | 29(15.8) | 99(64.3) | 15(71.4) |
ND① | 47(67.1) | 43(23.4) | 5(3.2) | 0 |